Annual Working Capital
$30.95 M
+$5.28 M+20.56%
31 December 2023
Summary:
Tempest Therapeutics annual working capital is currently $30.95 million, with the most recent change of +$5.28 million (+20.56%) on 31 December 2023. During the last 3 years, it has risen by +$14.35 million (+86.42%). TPST annual working capital is now -36.75% below its all-time high of $48.94 million, reached on 31 December 2021.TPST Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$9.58 M
-$7.41 M-43.62%
30 September 2024
Summary:
Tempest Therapeutics quarterly working capital is currently $9.58 million, with the most recent change of -$7.41 million (-43.62%) on 30 September 2024. Over the past year, it has increased by +$4.71 million (+96.73%). TPST quarterly working capital is now -84.22% below its all-time high of $60.70 million, reached on 30 June 2021.TPST Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TPST Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +20.6% | +96.7% |
| 3 y3 years | +86.4% | -83.0% |
| 5 y5 years | - | - |
TPST Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -36.8% | +86.4% | -83.0% | +96.7% |
| 5 y | 5 years | -36.8% | +86.4% | -84.2% | +96.7% |
| alltime | all time | -36.8% | +86.4% | -84.2% | +96.7% |
Tempest Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $9.58 M(-43.6%) |
| June 2024 | - | $16.99 M(-25.5%) |
| Mar 2024 | - | $22.81 M(-26.3%) |
| Dec 2023 | $30.95 M(+20.6%) | $30.95 M(+535.7%) |
| Sept 2023 | - | $4.87 M(-50.8%) |
| June 2023 | - | $9.90 M(-42.3%) |
| Mar 2023 | - | $17.16 M(-33.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $25.67 M(-47.5%) | $25.67 M(-29.1%) |
| Sept 2022 | - | $36.20 M(-21.1%) |
| June 2022 | - | $45.88 M(+9.5%) |
| Mar 2022 | - | $41.90 M(-14.4%) |
| Dec 2021 | $48.94 M(+194.7%) | $48.94 M(-13.2%) |
| Sept 2021 | - | $56.35 M(-7.2%) |
| June 2021 | - | $60.70 M(+265.6%) |
| Dec 2020 | $16.60 M | $16.60 M |
FAQ
- What is Tempest Therapeutics annual working capital?
- What is the all time high annual working capital for Tempest Therapeutics?
- What is Tempest Therapeutics annual working capital year-on-year change?
- What is Tempest Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Tempest Therapeutics?
- What is Tempest Therapeutics quarterly working capital year-on-year change?
What is Tempest Therapeutics annual working capital?
The current annual working capital of TPST is $30.95 M
What is the all time high annual working capital for Tempest Therapeutics?
Tempest Therapeutics all-time high annual working capital is $48.94 M
What is Tempest Therapeutics annual working capital year-on-year change?
Over the past year, TPST annual working capital has changed by +$5.28 M (+20.56%)
What is Tempest Therapeutics quarterly working capital?
The current quarterly working capital of TPST is $9.58 M
What is the all time high quarterly working capital for Tempest Therapeutics?
Tempest Therapeutics all-time high quarterly working capital is $60.70 M
What is Tempest Therapeutics quarterly working capital year-on-year change?
Over the past year, TPST quarterly working capital has changed by +$4.71 M (+96.73%)